O. Suchowersky And NotItalie
List of bibliographic references
Number of relevant bibliographic references: 25.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001277 | J.-M. Lee ; E. M. Ramos ; J.-H. Lee ; T. Gillis ; J. S. Mysore ; M. R. Hayden ; S. C. Warby ; P. Morrison ; M. Nance ; C. A. Ross ; R. L. Margolis ; F. Squitieri ; S. Orobello ; S. Di Donato ; E. Gomez-Tortosa ; C. Ayuso ; O. Suchowersky ; R. J. A. Trent ; E. Mccusker ; A. Novelletto ; M. Frontali ; R. Jones ; T. Ashizawa ; S. Frank ; M. H. Saint-Hilaire ; S. M. Hersch ; H. D. Rosas ; D. Lucente ; M. B. Harrison ; A. Zanko ; R. K. Abramson ; K. Marder ; J. Sequeiros ; J. S. Paulsen ; G. B. Landwehrmeyer ; R. H. Myers ; M. E. Macdonald ; J. F. Gusella | CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion |
| 001516 | D. Salat-Foix [Canada] ; K. Tran [Canada] ; R. Ranawaya [Canada] ; J. Meddings [Canada] ; O. Suchowersky [Canada] | Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg? |
| 001944 | D. Salat-Foix [Canada] ; C. N. Andrews [Canada] ; J. Meddings [Canada] ; O. Suchowersky [Canada] | Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management |
| 001C87 | A. Bharmal [Canada] ; C. Lu [Canada] ; J. Quickfall [Canada] ; D. Crockford [Canada] ; O. Suchowersky [Canada] | Outcomes of Patients with Parkinson Disease and Pathological Gambling |
| 002169 | M. Jog [Canada] ; M. Panisset ; O. Suchowersky ; B. Réhel ; R. Schecter | Naturalistic evaluation of entacapone in patients with signs and symptoms of L-dopa wearing-off . |
| 002185 | J. E. Tobin ; J. C. Latourelle ; M. F. Lew ; C. Klein ; O. Suchowersky ; H. A. Shill ; L. I. Golbe ; M. H. Mark ; J. H. Growdon ; G. F. Wooten ; B. A. Racette ; J. S. Perlmutter ; R. Watts ; M. Guttman ; K. B. Baker ; S. Goldwurm ; G. Pezzoli ; C. Singer ; M. H. Saint-Hilaire ; A. E. Hendricks ; S. Williamson ; M. W. Nagle ; J. B. Wilk ; T. Massood ; J. M. Laramie ; A. L. Destefano ; I. Litvan ; G. Nicholson ; A. Corbett ; S. Isaacson ; D. J. Burn ; P. F. Chinnery ; P. P. Pramstaller ; S. Sherman ; J. Al-Hinti ; E. Drasby ; M. Nance ; A. T. Moller ; K. Ostergaard ; R. Roxburgh ; B. Snow ; J. T. Slevin ; F. Cambi ; J. F. Gusella ; R. H. Myers | Haplotypes and gene expression implicate the MAPT region for Parkinson disease |
| 002230 | T R Thomsen [Canada] ; M. Panisset [Canada] ; O. Suchowersky [Canada] ; A. Goodridge [Canada] ; T. Mendis [Canada] ; A E Lang [Canada] | Impact of standard of care for psychosis in Parkinson disease |
| 002434 | A. Haffenden [Canada] ; U. Khan ; Z H T. Kiss ; O. Suchowersky | Surgery for Parkinson's disease improves disability but not impairment components of the UPDRS-II. |
| 002703 | R B Postuma [Canada] ; A J Espay ; C. Zadikoff ; O. Suchowersky ; W R W. Martin ; A-L Lafontaine ; R. Ranawaya ; R. Camicioli ; A E Lang | Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. |
| 002719 | O. Suchowersky [Canada] ; G. Gronseth ; J. Perlmutter ; S. Reich ; T. Zesiewicz ; W J Weiner | Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. |
| 002721 | O. Suchowersky [Canada] ; S. Reich ; J. Perlmutter ; T. Zesiewicz ; G. Gronseth ; W J Weiner | Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. |
| 002890 | R. B. Postuma [Canada] ; A. J. Espay [Canada] ; C. Zadikoff [Canada] ; O. Suchowersky [Canada] ; W. R. W. Martin [Canada] ; A.-L. Lafontaine [Canada] ; R. Ranawaya [Canada] ; R. Camicioli [Canada] ; A. E. Lang [Canada] | Vitamins and entacapone in levodopa-induced hyperhomocysteinemia : A randomized controlled study |
| 002910 | O. Suchowersky [Canada] ; G. Gronseth [États-Unis] ; J. Perlmutter [États-Unis] ; S. Reich [États-Unis] ; T. Zesiewicz [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter:Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology |
| 002912 | O. Suchowersky [Canada] ; S. Reich [États-Unis] ; J. Perlmutter [États-Unis] ; T. Zesiewicz [États-Unis] ; G. Gronseth [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter:Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology |
| 002F61 | S. Furtado [Canada] ; M. Farrer ; Y. Tsuboi ; M L Klimek ; R. De La Fuente-Fernández ; J. Hussey ; P. Lockhart ; D B Calne ; O. Suchowersky ; A J Stoessl ; Z K Wszolek | SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. |
| 003551 | D. J. Chong [Canada] ; O. Suchowersky [Canada] ; C. Szumlanski [États-Unis] ; R. M. Weinshilboum [États-Unis] ; R. Brant [Canada] ; N. R. C. Campbell [Canada] | The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's Disease |
| 003808 | M. Guttman [Canada] ; O. Suchowersky [Canada] | Parkinson's disease management : Towards a new paradigm |
| 003816 | T. Mendis [Canada] ; O. Suchowersky [Canada] ; A. Lang [Canada] ; S. Gauthier [Canada] | Management of Parkinson's disease : A review of current and new therapies |
| 003836 | J. Rivest [Canada] ; C. L. Barclay [Canada] ; O. Suchowersky [Canada] | COMT inhibitors in Parkinson's disease |
| 003C35 | I. H. Richard [États-Unis] ; R. Kurlan [États-Unis] ; C. Tanner [États-Unis] ; S. Factor [États-Unis] ; J. Hubble [États-Unis] ; O. Suchowersky [Canada] ; C. Waters [États-Unis] | Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease |
| 004103 | O. Suchowersky [Canada] ; S. Furtado ; G. Rohs | Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease |
| 004E96 | C. B. Bozek ; O. Suchowersky ; S. Purves ; S. Calne ; D. B. Calne | Sinemet in Parkinson's disease: efficacy with and without food |
| 005131 | Jerilynn C. Prior [Canada] ; E. C. Cameron [Canada] ; W. J. Knickerbocker [Canada] ; Vincent P. Sweeney [Canada] ; O. Suchowersky [Canada] | Dialysis encephalopathy and osteomalacic bone disease |
| 005588 | D J Chong [Canada] ; O. Suchowersky ; C. Szumlanski ; R M Weinshilboum ; R. Brant ; N R Campbell | The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease. |
| 005653 | O. Suchowersky [Canada] ; P. Bailey ; E. Pourcher ; L. Bulger ; G. Facciponte | Comparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD. |
| This area was generated with Dilib version V0.6.29. |  |